Galapagos NV:企業のM&A・事業提携・投資動向

◆英語タイトル:Galapagos NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2067
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:261
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Galapagos NV – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Galapagos NV since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Galapagos NV’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Galapagos NV. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Galapagos NV’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Galapagos NV and its subsidiaries since 2007.
- Information about key financial and legal advisors for Galapagos NV’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Galapagos NV’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Deal reports 7
PARTNERSHIP 17
Partnership – Overview 17
Partnership – Deal reports 18
CAPITAL RAISING 224
Capital Raising – Overview 224
Capital Raising – Deal reports 225
DIVESTMENTS 239
Divestments – Overview 239
Divestments – Deal reports 240
PRIVATE EQUITY & OWNERSHIP 246
Private Equity and Ownership – Deal reports 246
APPENDIX 251
Contact Us 251
About MarketLine Financial Deals Database 251
Deal Definition and Methodology 253
About MarketLine 260

List of Tables
Table 1: Galapagos NV partnership volume and value trend (2014-YTD2018)
Table 2: Galapagos NV partnership trend by key deal type (2014-YTD2018)
Table 3: Galapagos NV capital raising volume and value trend (2014-YTD2018)
Table 4: Galapagos NV capital raising by deal type (2014-YTD2018)
Table 5: Galapagos NV divestments volume and value trend (2014-YTD2018)
Table 6: Galapagos NV divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Galapagos NV partnership volume and value trend (2014-YTD2018)
Figure 2: Galapagos NV partnership trend by key deal type (2014-YTD2018)
Figure 3: Galapagos NV capital raising volume and value trend (2014-YTD2018)
Figure 4: Galapagos NV capital raising by deal type (2014-YTD2018)
Figure 5: Galapagos NV divestments volume and value trend (2014-YTD2018)
Figure 6: Galapagos NV divestments by geography (2014-YTD2018)

★海外企業調査レポート[Galapagos NV:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • PayPal Holdings Inc:企業の戦略・SWOT・財務情報
    PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MDI Achieve Inc:医療機器:M&Aディール及び事業提携情報
    Summary MDI Achieve Inc (MDI), formerly MDI Technologies Inc is a technology company that designs, develops and commercializes financial and clinical management solutions. The company offers MatrixCare software solutions helps in clinical and resident management, analytics management, financial mana …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Amphastar Pharmaceuticals Inc (AMPH)-製薬・医療分野:企業M&A・提携分析
    Summary Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s product …
  • Mosman Oil & Gas Ltd (MSMN):石油・ガス:M&Aディール及び事業提携情報
    Summary Mosman Oil & Gas Ltd (MOG) is an oil and gas company. The company operates in the exploration, development, and production of oil and gas projects. Its projects include amadeus basin, welch permian basin, blackstone strategic alliance, strawn oil project, and arkoma stacked pay project. MOG’ …
  • Biogen Inc (BIIB)-製薬・医療分野:企業M&A・提携分析
    Summary Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbry …
  • Xencor Inc (XNCR):企業の財務・戦略的SWOT分析
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the …
  • Covanta Holding Corporation
    Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Wistar Institute-医療機器分野:企業M&A・提携分析
    Summary The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training in cancer, infectious diseases, immunology and vaccine development. The institute conducts research on genes, gene expression, and DNA biology; cancer biology; translational resear …
  • Orange Polska S.A.:戦略・SWOT・企業財務分析
    Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ohio State University Comprehensive Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Ohio State University Comprehensive Cancer Center (OSUCCC), a subsidiary of Ohio State University, is a healthcare institute that offers medical and academic education services. The institute provides education, research, and patient care services. Its services comprise cancer diagnosis, tre …
  • Bank of Montreal:企業のM&A・事業提携・投資動向
    Bank of Montreal - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Montreal Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Delphi Automotive Plc (APTV):企業の財務・戦略的SWOT分析
    Delphi Automotive Plc (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Martinrea International Inc:企業の戦略・SWOT・財務情報
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Clinical Laserthermia Systems AB (CLS B):医療機器:M&Aディール及び事業提携情報
    Summary Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company's flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a preci …
  • Genocea Biosciences Inc (GNCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Genocea Biosciences Inc (Genocea), formerly GenoceaInc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tech …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • U.S. HealthWorks Medical Group:製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health, is a healthcare service provider that offers medicine and urgent care services. The center’s services include occupational medicine, urgent care, specialty care and therapy services. Its occupational medicine …
  • Corporacion Electrica Nacional SA:企業の戦略的SWOT分析
    Corporacion Electrica Nacional SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆